These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 665427)

  • 1. Reduced induction of drug metabolism in the elderly.
    Salem SA; Rajjayabun P; Shepherd AM; Stevenson IH
    Age Ageing; 1978 May; 7(2):68-73. PubMed ID: 665427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylaxis after dichloralphenazone treatment.
    Perl S
    Br Med J; 1977 Nov; 2(6096):1187-8. PubMed ID: 589077
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).
    Breckenridge A; Orme ML; Thorgeirsson S; Davies DS; Brooks RV
    Clin Sci; 1971 Apr; 40(4):351-64. PubMed ID: 5575281
    [No Abstract]   [Full Text] [Related]  

  • 5. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of estrogens on pharmacokinetics of phenazone and N-acetyl-p-aminophenol].
    Kwiatkowski A
    Ann Acad Med Stetin; 1991; 37():35-47. PubMed ID: 1816754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of enzyme induction.
    Breckenridge A; Orme M
    Ann N Y Acad Sci; 1971 Jul; 179():421-31. PubMed ID: 5285387
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
    Orzechowska-Juzwenko K; Wiela-Hojeńska A; Milejski P; Cieślińska A; Hudziec P; Adamska M
    Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.
    Groen K; Horan MA; Roberts NA; Gulati RS; Miljkovic B; Jansen EJ; Paramsothy V; Breimer DD; van Bezooijen CF
    Clin Pharmacokinet; 1993 Aug; 25(2):136-44. PubMed ID: 8403737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Michaëlis--Menten kinetics of phenazone elimination in the perfused pig liver.
    Andreasen B; Tonnesen K; Rabol A; Keiding S
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):1-13. PubMed ID: 576352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial.
    Diamond S
    Headache; 1976 Jan; 15(4):282-7. PubMed ID: 1107267
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of chlormethiazole and dichloralphenazone: a sedative/hypnotic in geriatric medicine.
    Pathy MS
    Curr Med Res Opin; 1974-1975; 2(10):648-56. PubMed ID: 4616805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-effect of dichloralphenazone.
    GHOSH M
    Br Med J; 1963 Mar; 1(5330):611. PubMed ID: 13947524
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.
    Breckenridge A; Orme ML; Davies DS; Thorgeirsson S
    Clin Sci; 1969 Oct; 37(2):565. PubMed ID: 5359008
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs.
    Vesell ES; Lee CJ; Passananti GT; Shively CA
    Pharmacology; 1973; 10(6):317-28. PubMed ID: 4150321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.